GoHealth, Inc. GOCOQ
0.34
0.00
0.00%
as of 28 Jul
- Market cap
- $8.5M
- P/E
- 0.0×
Follow GOCOQ
| Older periods | Jun '25 | Sep '25 | Dec '25 | Mar '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.07 | 0.09 | 0.08 | 0.16 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(1.59) | (2.09) | (0.71) | 3.50 | |
P/B ratio |
0.22 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.78 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.97 | 1.12 | 2.29 | 5.15 | |
EV/EBITDA |
13.89 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(16.71) | (12.11) | (6.79) | (7.67) | |
EV/FCF |
(13.28) | (10.50) | (6.36) | (7.10) | |
Quick Ratio |
1.42 | 1.54 | 1.93 | 1.95 | |
Current Ratio |
1.56 | 1.64 | 2.02 | 2.03 | |
Net Debt/EBITDA |
(9.70) | (2.78) | (26.25) | (24.25) | |
Debt/Assets |
56.10% | 72.87% | 80.34% | 87.40% | |
Debt/Equity |
2.64 | (108.70) | (12.75) | (6.33) | |
Asset Turnover |
0.64 | 0.62 | 0.29 | 0.13 | |
Operating CF/Net income |
0.70 | 0.20 | 1.10 | (0.18) | |
Capex/Depreciation |
(0.10) | (0.08) | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
81.03% | 182.42% | 260.09% | 257.94% | |
Intangible Assets out of Total Assets |
0.15 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
(0.14%) | 10.23% | 23.78% | 21.55% | |
Graham Net Nets |
(12.36) | (11.01) | (27.45) | (31.88) | |
Graham Number |
0.00 | 12.84 | 44.67 | 59.76 | |
Earnings Yield |
(47.21%) | (311.20%) | (858.14%) | (1,343.71%) | |
Free Cash Flow Yield |
(100.14%) | (115.56%) | (467.97%) | (453.08%) | |
Revenue per Share |
8.68 | 2.42 | 0.98 | 0.74 | |
Operating CF per Share |
(3.49) | (2.31) | (3.02) | 0.43 | |
Capex per Share |
(0.26) | (0.17) | 0.00 | 0.00 | |
Free Cash Flow per Share |
(3.75) | (2.48) | (3.02) | 0.43 | |
Cash per Share |
3.29 | 2.27 | 2.54 | 2.46 | |
Shareholders Equity per Share |
25.77 | (0.49) | (4.81) | (7.82) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
25.77 | (0.49) | (4.81) | (7.82) | |
Free Cash Flow |
(40.65) | (35.02) | (39.07) | 6.99 | |
Working Capital |
103.80 | 111.78 | 144.29 | 134.67 | |
Capital Expenditures |
(2.83) | (2.37) | 0.00 | — | |
Net Current Asset Value |
(743.17) | (749.93) | (763.80) | (779.71) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.03 | 0.07 | 0.00 | 0.00 | |
Net Profit Margin |
(57.71%) | (485.13%) | (281.38%) | (320.59%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
250.41 | 258.10 | 282.28 | 213.95 | |
Average Payables |
14.98 | 13.57 | 10.76 | 14.38 | |
Average Assets |
1,284.07 | 1,185.82 | 1,237.90 | 1,149.99 | |
Average Common Equity |
303.45 | 169.18 | 171.62 | 135.19 |
Columns are period end dates